Natural regeneration-inspired sequential delivery of synergistic growth factors for structural and functional endometrial regeneration
article
OA: closed
CC0
AI-generated summary
This paper investigates sequential delivery of synergistic growth factors to promote structural and functional endometrial regeneration, inspired by natural regenerative processes.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Large-scale deep endometrial injury has a serious impact on the reproductive health of women, necessitating the development of novel therapeutic approaches. Treatment strategies using single factor may not perfectly match the intricate and dynamic process of endometrial regeneration. In light of the sequential progression of vascularization and endometrial remodeling observed during the regeneration of injured endometrium, a dual growth factor sequential delivery system is prepared by loading IGF-1 onto hydrogel microspheres and blending with an outer bulk hydrogel containing VEGF. The controlled degradation of hydrogel facilitates the sequential release of the two factors, thereby fostering the vascularization, migration and proliferation of endometrial cells in vitro. Animal experiments have proved that the hydrogel system can promote the regeneration of endometrial structure through vascular remodeling, glandular regeneration, and proliferation of endometrial cells, and simultaneously improve the rate of embryo implantation and live birth, which further indicates the functional reconstruction of the injured endometrium. Consequently, drawing inspiration from the sequential process of endometrial regeneration, this study provides innovative strategies for structural and functional restoration of the endometrium. STATEMENT OF SIGNIFICANCE: This research presents an innovative approach to the treatment of injured endometrium through a sequential dual growth factor delivery system. The system involves the incorporation of IGF-1 onto hydrogel microspheres, which are subsequently embedded within a GelMA hydrogel matrix containing VEGF. Unlike conventional hydrogel-based therapeutic strategies that involve the loading of growth factors, the developed delivery system is engineered in accordance with the vascularization and endometrial remodeling processes inherent to the regeneration of injured endometrial tissue. It facilitates the initial release of VEGF to stimulate the formation of blood vessels, followed by a gradual release of IGF-1 during the intermediate phase of endometrial regeneration to promote tissue remodeling. Pre-clinical animal studies have demonstrated that this innovative delivery strategy effectively restores the structure and function of the endometrium, suggesting significant potential for clinical application.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (65)
- An injectable gelatin/sericin hydrogel loaded with human umbilical cord mesenchymal stem cells for the treatment of uterine injury via openalex
- An integrated single-cell reference atlas of the human endometrium via openalex
- Injectable antioxidant hyaluronan/chitosan hydrogel as a platelet-rich plasma and stem cell carrier to promote endometrial regeneration and fertility restoration via openalex
- Locationally activated PRP via an injectable dual-network hydrogel for endometrial regeneration via openalex
- Mechanisms of Regeneration and Fibrosis in the Endometrium via openalex
- Mesenchymal Stem Cell Derived Exosomes Repair Uterine Injury by Targeting Transforming Growth Factor-β Signaling via openalex
- Sodium alginate hydrogel integrated with type III collagen and mesenchymal stem cell to promote endometrium regeneration and fertility restoration via openalex
- TSG6‐Exo@CS/GP Attenuates Endometrium Fibrosis by Inhibiting Macrophage Activation in a Murine IUA Model via openalex
- W4210296280 via openalex
- W4281253181 via openalex
- W4282974763 via openalex
- W4285744535 via openalex
- W4296162203 via openalex
- W4307139533 via openalex
- W4313830852 via openalex
- W4318206821 via openalex
- W4361278231 via openalex
- W4366977628 via openalex
- W4372403612 via openalex
- W4376877882 via openalex
- W4380884764 via openalex
- W4385332596 via openalex
- W4386401880 via openalex
- W4386773795 via openalex
- W4386817823 via openalex
- W4387191316 via openalex
- W4388698725 via openalex
- W4388713773 via openalex
- W4388911952 via openalex
- W4389144253 via openalex
- W4390953170 via openalex
- W4391165155 via openalex
- W4391559319 via openalex
- W4391611697 via openalex
- W4392087723 via openalex
- W4393011710 via openalex
- W4393064633 via openalex
- W4397033144 via openalex
- W4400225139 via openalex
- W4401651867 via openalex
- W4402007256 via openalex
- W4403624991 via openalex
- W4404506937 via openalex
- W4404572228 via openalex
- W4404733606 via openalex
- W4405110295 via openalex
- W4407862114 via openalex
- W4409383237 via openalex
- W4409443699 via openalex
- W6840027107 via openalex
- W6850382740 via openalex
- W6858226517 via openalex
- W6858622146 via openalex
- W6861684845 via openalex
- W6862166423 via openalex
- W6871259035 via openalex
- doi:10.1002/adma.202407750 via openalex
- W6871620191 via openalex
- doi:10.1038/s41421-022-00438-7 via openalex
- W2580465055 via openalex
- W2991026949 via openalex
- W3116794366 via openalex
- W3126390427 via openalex
- W3166576400 via openalex
- W3197636532 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK